Viewing StudyNCT00032773

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00032773
Status: TERMINATED
Last Update Posted: 2020-10-23
First Post: 2002-04-02
Brief Title: Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD
Sponsor: Astex Pharmaceuticals Inc
Organization: Astex Pharmaceuticals Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Acute Graft Versus Host Disease
Keywords:
Name View
deoxycoformycin View
acute graft versus host disease View
aGVHD View
allogeneic hematopoietic stem cell transplantation View
peripheral blood stem cell transplantation View
cord blood transplant View
pentostatin View
Nipent View